Cedara has received FDA clearance for its I-ReadMammo breast imaging workstation. The new product, which supports images from multiple modalities and various mammography vendors (SCAN 5/5/04), will begin shipping this summer. It will be marketed directly
Cedara has received FDA clearance for its I-ReadMammo breast imaging workstation. The new product, which supports images from multiple modalities and various mammography vendors (SCAN 5/5/04), will begin shipping this summer. It will be marketed directly by Cedara, as well as through OEMs and distributors.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.